| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |